How are we going to get the general population to sign-up for screening for neurodegenerative diseases? #PreventiveNeurology Two of the three diseases we are targeting as part of our Preventive Neurology initiative will capture people with Diffuse Lewy Body (DLB) disease, i.e. Parkinson's disease and all-cause dementia. The BMJ commentary and DLB consensus report highlight the problem of misdiagnosis. If we are careful and embed in our prediction algorithms the right patient-related outcome measures and cognitive testing we should be able to identify a cohort of people with early DLB. May be this is wishful thinking. One of the obstacles we are going to find is getting members of the general population to sign-up for screening. Any ideas? Joseph Freer. UK lags far behind Europe on diagnosis of dementia with Lewy bodies . BMJ 2017;358:j3319 Excerpts : ..... Around half of UK patients who have dementia with Lewy bodies (DLB)—about 60 000 people—have it misdia...